The global Advanced Therapy Medicinal Products (ATMPs) market was valued at USD 45.8 billion in 2023 and is expected to reach more than USD 245.1 billion by the end of 2034. Driven by rapid advancements in gene and cell therapies, increasing approvals of regenerative medicines, and growing investment in personalized healthcare, the market is projected to expand at a robust CAGR of...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek